Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
 
research article

Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease

Gervais, Adrian
•
Bastard, Paul
•
Bizien, Lucy
Show more
November 1, 2024
Journal Of Experimental Medicine

Arboviral diseases are a growing global health concern. Pre-existing autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) can underlie encephalitis due to West Nile virus (WNV) (similar to 40% of patients) and tick-borne encephalitis (TBE, due to TBE virus [TBEV]) (similar to 10%). We report here that these auto-Abs can also underlie severe forms of rarer arboviral infections. Auto-Abs neutralizing high concentrations of IFN-alpha 2, IFN-beta, and/or IFN-omega are present in the single case of severe Powassan virus (POWV) encephalitis studied, two of three cases of severe Usutu virus (USUV) infection studied, and the most severe of 24 cases of Ross River virus (RRV) disease studied. These auto-Abs are not found in any of the 137 individuals with silent or mild infections with these three viruses. Thus, auto-Abs neutralizing type I IFNs underlie an increasing list of severe arboviral diseases due to Flaviviridae (WNV, TBEV, POWV, USUV) or Togaviridae (RRV) viruses transmitted to humans by mosquitos (WNV, USUV, RRV) or ticks (TBEV, POWV).

  • Details
  • Metrics
Type
research article
DOI
10.1084/jem.20240942
Web of Science ID

WOS:001346019000001

PubMed ID

39485284

Author(s)
Gervais, Adrian

Universite Paris Cite

Bastard, Paul

Rockefeller University

Bizien, Lucy

Universite Paris Cite

Delifer, Celine

Etab Francais Sang

Tiberghien, P.

Etab Francais Sang

Rodrigo, Chaturaka

University of New South Wales Sydney

Trespidi, Francesca

San Matteo Res Hosp

Angelini, Micol

San Matteo Res Hosp

Rossini, Giada

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lazzarotto, Tiziana

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Show more
Date Issued

2024-11-01

Publisher

ROCKEFELLER UNIV PRESS

Published in
Journal Of Experimental Medicine
Volume

221

Issue

12

Article Number

e20240942

Subjects

SEVERE COVID-19

•

AUTOANTIBODIES

•

INFECTION

•

Science & Technology

•

Life Sciences & Biomedicine

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
UPFELLAY  
FunderFunding(s)Grant NumberGrant URL

Howard Hughes Medical Institute

R01AI163029

Rockefeller University

St. Giles Foundation

Show more
Available on Infoscience
January 28, 2025
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/245605
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés